Indonesia Volcano Eruption Forces Evacuations, Airport Closure

A handout photo taken and released by Center for Volcanology and Geological Hazard Mitigation (PVMBG) on April 18, 2024 shows Mount Ruang spewing smoke in Sitaro, North Sulawesi. (Photo by Handout / Center for Volcanology and Geological Hazard Mitigation (PVMBG) / AFP)
A handout photo taken and released by Center for Volcanology and Geological Hazard Mitigation (PVMBG) on April 18, 2024 shows Mount Ruang spewing smoke in Sitaro, North Sulawesi. (Photo by Handout / Center for Volcanology and Geological Hazard Mitigation (PVMBG) / AFP)
TT

Indonesia Volcano Eruption Forces Evacuations, Airport Closure

A handout photo taken and released by Center for Volcanology and Geological Hazard Mitigation (PVMBG) on April 18, 2024 shows Mount Ruang spewing smoke in Sitaro, North Sulawesi. (Photo by Handout / Center for Volcanology and Geological Hazard Mitigation (PVMBG) / AFP)
A handout photo taken and released by Center for Volcanology and Geological Hazard Mitigation (PVMBG) on April 18, 2024 shows Mount Ruang spewing smoke in Sitaro, North Sulawesi. (Photo by Handout / Center for Volcanology and Geological Hazard Mitigation (PVMBG) / AFP)

Indonesia shut a provincial airport and evacuated hundreds of people from the vicinity of the Ruang volcano after it belched explosive plumes of lava, rocks and ash for days, officials said on Thursday, declaring the highest alert on the situation.
Wednesday's dramatic eruption of the volcano on a remote island in the province of North Sulawesi threw a fiery-red column of lava, incandescent rock and ash as much as three km into the sky.
Purple flashes of lightning rent the sky above the erupting volcano, videos on social media showed.
"We're running, guys," said one witness who filmed the eruption while scrambling to evacuate. "We are escaping because the ash is coming close."
More than 800 people were evacuated from the area, with authorities widening the evacuation zone further after the volcanology agency raised the alert status.
"The potential for further eruption is still high, so we need to remain alert," agency official Heruningtyas Desi Purnamasari told reporters on Thursday, blaming a rapid escalation in volcanic activity.
The agency had also received reports that falling rocks and ash damaged homes and forced a nearby hospital to evacuate, the official said.
Transport authorities shut the airport in the provincial capital of Manado to protect against the showers of ash from the eruption.
Budget airline Air Asia cancelled flights with nine airports in East Malaysia and Brunei after aviation authorities warned of a safety threat.
Officials have cordoned off an area of six kilometers around the volcano and are evacuating more residents, some from the neighboring island of Tagulandang, said Abdul Muhari, spokesperson of the disaster mitigation agency.
About 1,500 of those in high-risk areas needed to be immediately evacuated, he added, while almost 12,000 more stand to be affected.
Officials have also flagged the risk of a tsunami if parts of the mountain collapse into the ocean below. About 400 people were killed in a tsunami unleashed by a previous eruption of the volcano in 1871.

Indonesia, an archipelago of 270 million people, has 120 active volcanoes. It is prone to volcanic activity because it sits along the “Ring of Fire,” a horseshoe-shaped series of seismic fault lines around the Pacific Ocean.



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”